Mesothelioma Detection and Diagnosis Study

Italian researchers carried out a mesothelioma detection and diagnosis study over one to two years with a role indicated for mesothelioma in asbestos-exposed mesothelioma, asbestos, mesothelioma cancerworkers.  The mesothelioma detection and diagnosis study used a soluble mesothelin-related peptide (SMRP) to determine if mesothelioma detection and diagnosis study could be used as a marker early stage mesothelioma.

The researchers in the mesothelioma detection and diagnosis study investigated the SMRP upfront predictive role for mesothelioma in asbestos-exposed workers.  Unfortunately, the researchers determined that the soluble mesothelin-related peptide (SMRP) was not a good marker for early detection of mesothelioma.

Mesothelioma is a disease connected to asbestos exposure.   Malignant (cancerous) mesothelioma – which has been closely linked to or is caused by exposure to asbestos fibers is a horrible and devastating rare form of cancer that occurs in the mesothelium – a thin protective layer of tissue that covers the majority of your internal organs.

People who develop this rare form of cancer were most likely exposed to dangerous asbestos fibers while working in various industries to support their families. It is common for the development of mesothelioma to occur 20 or sometimes even 40 years after initial exposure to asbestos.

asbestos, mesothelioma, sophisticated user, cancerAsbestos fibers have been used in the manufacturing of a wide variety of industrial and household products in the United States and around the world.  Mesothelioma has been linked to asbestos exposure and second hand asbestos exposure.  And more recently, mesothelioma or lung cancer has even been found to be connected to people who smoke cigarettes.

For more on mesothelioma and asbestos, please visit the links below:


At the Gooch Law Firm, we pride ourselves on providing our clients reliable representation for even the most challenging cases. If you have been diagnosed with mesothelioma, contact our office at 1.844.329.5955.